Interleukin-17 Expression Positively Correlates with Disease Severity of Lupus Nephritis by Increasing Anti-Double-Stranded DNA Antibody Production in a Lupus Model Induced by Activated Lymphocyte Derived DNA

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wen, Zhenke ^a   Xu, Lin ^a   Xu, Wei ^b   Yin, Zhinan ^b   Gao, Xiaoming ^b   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 17; ANTINUCLEAR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; COMPLEMENT ACTIVATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KIDNEY; LYMPHOCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEINURIA; TRANSGENIC MOUSE; URINE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; DNA; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-17; KIDNEY; LUPUS NEPHRITIS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PROTEINURIA;

EID: 84874611415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058161     Document Type: Article

References (43)

1. Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, et al. (2003) Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 62: 556-560.
2. Apostolidis SA, Crispín JC, Tsokos GC, (2011) IL-17-producing T cells in lupus nephritis. Lupus 20: 120-124.
3. Adalid-Peralta L, Mathian A, Tran T, Delbos L, Durand-Gasselin I, et al. (2008) Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis. Kidney Int 73: 172-180.
4. Cohen RA, Bayliss G, Crispin JC, Kane-Wanger GF, Van Beek CA, et al. (2008) T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol 128: 1-7.
5. Miyake K, Akahoshi M, Nakashima H, (2011) Th subset balance in lupus nephritis. J Biomed Biotechnol 2011: 980286.
6. Xing Q, Wang B, Su H, Cui J, Li J, (2012) Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 32: 949-958.
7. Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, et al. (2012) The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 21: 1385-1396.
8. Garrett-Sinha LA, John S, Gaffen SL, (2008) IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 20: 519-525.
9. Hemdan NY, Birkenmeier G, Wichmann G, Abu El-Saad AM, Krieger T, et al. (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9: 785-792.
10. Chen XQ, Yu YC, Deng HH, Sun JZ, Dai Z, et al. (2010) Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J Clin Immunol 30: 221-225.
11. Kang HK, Ecklund D, Liu M, Datta SK, (2009) Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther 11: R59.
12. Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, et al. (2008) Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 181: 8761-8766.
13. Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, et al. (2010) Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 159: 1-10.
14. Qiao B, Wu J, Chu YW, Wang Y, Wang DP, et al. (2005) Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA. Rheumatology (Oxford) 44: 1108-1114.
15. Wen ZK, Xu W, Xu L, Cao QH, Wang Y, et al. (2007) DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46: 1796-1803.
16. Zhang W, Xu W, Xiong S, (2010) Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 184: 6465-6478.
17. Zhang W, Wu J, Qiao B, Xu W, Xiong S, (2011) Amelioration of lupus nephritis by serum amyloid p component gene therapy with distinct mechanisms varied from different stage of the disease. PLoS One 6: e22659.
18. Zhang W, Xu W, Xiong S, (2011) Macrophage Differentiation and Polarization via Phosphatidylinositol 3-Kinase/Akt-ERK Signaling Pathway Conferred by Serum Amyloid P Component. J Immunol 187: 1764-1777.
19. Wen Z, Xu L, Xu W, Xiong S, (2012) Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4+ T cells. Lupus 21: 508-516.
20. Hutcheson J, Scatizzi JC, Siddiqui AM, Haines GK 3rd, Wu T, et al (2008) Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217.
21. Wang D, John SA, Clements JL, Percy DH, Barton KP, et al. (2005) Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol 17: 1179-1191.
22. Leng L, Chen L, Fan J, Greven D, Arjona A, et al. (2011) A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. J Immunol 186: 527-538.
23. Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, et al. (2000) Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice. Eur J Immunol 30: 438-447.
24. Schwarzenberger P, La Russa V, Miller A, Ye P, Huang W, et al. (1998) IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 161: 6383-6389.
25. Hsu HC, Yang P, Wang J, Wu Q, Myers R, et al. (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166-175.
26. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH, (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 177: 7980-7989.
27. Swaak AJ, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp EW, (1982) Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 41: 388-395.
28. von Mühlen CA, Tan EM, (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24: 323-358.
29. Rahman A, Isenberg DA, (2008) Systemic lupus erythematosus. N Engl J Med 358: 929-939.
30. Gaffen SL, (2011) Recent advances in the IL-17 cytokine family. Curr Opin Immunol 23: 613-619.
31. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
32. Kang HK, Liu M, Datta SK, (2007) Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory CD4+IL-17-producing cells. J Immunol 178: 7849-7858.
33. Wu HY, Quintana FJ, Weiner HL, (2008) Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells. J Immunol 181: 6038-6050.
34. Miossec P, Korn T, Kuchroo VK, (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898.
35. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, et al. (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2: 52ra72.
36. Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, et al. (2010) LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62: 929-939.
37. Mitsdoerffer M, Lee Y, Jäger A, Kim HJ, Korn T, et al. (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107: 14292-14297.
38. Barbosa RR, Silva SP, Silva SL, Melo AC, Pedro E, et al. (2011) Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS One 6: e22848.
39. Mountz JD, Wang JH, Xie S, Hsu HC, (2011) Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease. Discov Med 11: 76-85.
40. Nakae S, Nambu A, Sudo K, Iwakura Y, (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177.
41. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, et al. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
42. Dong G, Ye R, Shi W, Liu S, Wang T, et al. (2003) IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med J (Engl) 116: 543-548.
43. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, et al. (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10: 778-785.